Last reviewed · How we verify
NCT05129930
Fluid Overload and Pulmonary Function
trial in Water-Electrolyte Imbalance in 40 participants. Completed in 1 May 2021.
20 February 2021
Quick facts
| Lead sponsor | Pirogov Russian National Research Medical University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 40 |
| Start date | 1 December 2020 |
| Primary completion | 20 February 2021 |
| Estimated completion | 1 May 2021 |
| Sites | 1 location across Russia |
Conditions studied
- Water-Electrolyte Imbalance — all drugs for Water-Electrolyte Imbalance →
- Intensive Care Units — all drugs for Intensive Care Units →
- Pediatric — all drugs for Pediatric →
- Critical Illness — all drugs for Critical Illness →
Sponsor
Pirogov Russian National Research Medical University
Who can join
Adults 1 Month to 3, any sex, with Water-Electrolyte Imbalance or Intensive Care Units. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Esophageal atresia is a rare but severe malformation, and it requires early surgery. Coloesophagoplasty is surgical repair of the esophageal with an isoperistaltic transverse colon graft. In the postoperative period after coloesophagoplasty children require careful monitoring of fluid balance, because clinically significant fluid overload can lead to dysfunction of various organs and systems.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05129930
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Water-Electrolyte Imbalance
Currently open trials in the same condition.
- NCT05772364 — High- Versus Low-calcium Water for Bone Health · NA · recruiting
Other Pirogov Russian National Research Medical University trials
Trials by the same sponsor.
- NCT07449728 — The Influence of Laser Crossectomy With Different Wavelengths on Varicose Vein Progression · NA · recruiting
- NCT07363603 — Tianasen (ASO-GNAO1) for GNAO1-Encephalopathy With Epilepsy and Movement Disorders. · Phase 1, PHASE2 · recruiting
- NCT07083986 — Carotid Endarterectomy Versus Stenting in Patients With Acute Stage of Ischemic Stroke. · NA · enrolling by invitation
- NCT06766968 — Prolonged Compression Following Foam Sclerotherapy · NA · active not recruiting
- NCT06753786 — Timing of Venous Thromboembolism Prophylaxis in Patients With Hypertensive Intracerebral Hemorrhage · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05129930 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Pirogov Russian National Research Medical University
- Last refreshed: 22 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05129930.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing